Amneal Gets OxyContin Patent Nixed At PTAB
The U.S. Patent Trial and Appeal Board on Wednesday ruled that Amneal Pharmaceuticals LLC had sufficiently shown that an OxyContin patent belonging to Purdue Pharma LP is obvious over prior art...To view the full article, register now.
Already a subscriber? Click here to view full article